Holen Sie sich die Stockscreener-App
40.24
1.66%
-0.68
Handel nachbörslich:
40.24
Schlusskurs vom Vortag:
$40.92
Offen:
$40.21
24-Stunden-Volumen:
383.39K
Relative Volume:
0.51
Marktkapitalisierung:
$2.34B
Einnahmen:
$32.87M
Nettoeinkommen (Verlust:
$674.31M
KGV:
3.5423
EPS:
11.36
Netto-Cashflow:
$-330.11M
1W Leistung:
-1.54%
1M Leistung:
+9.41%
6M Leistung:
+46.22%
1J Leistung:
-2.52%
1-Tages-Spanne:
$39.71
$41.09
1-Wochen-Bereich:
$39.71
$43.21
52-Wochen-Spanne:
$23.41
$62.58
Agios Pharmaceuticals Inc Stock (AGIO) Company Profile
Firmenname
Agios Pharmaceuticals Inc
Sektor
Branche
Telefon
617-649-8600
Adresse
88 SIDNEY STREET, CAMBRIDGE, MA
Vergleichen Sie AGIO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AGIO
Agios Pharmaceuticals Inc
|
40.24 | 2.38B | 32.87M | 674.31M | -330.11M | 11.36 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Agios Pharmaceuticals Inc Stock (AGIO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-02-24 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-10-16 | Eingeleitet | Scotiabank | Sector Outperform |
| 2024-10-10 | Fortgesetzt | Raymond James | Outperform |
| 2024-09-27 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-02-08 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-02-03 | Eingeleitet | Piper Sandler | Overweight |
| 2022-11-17 | Hochstufung | Goldman | Sell → Neutral |
| 2022-07-27 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
| 2021-12-03 | Eingeleitet | BofA Securities | Buy |
| 2021-07-30 | Herabstufung | Goldman | Neutral → Sell |
| 2021-07-01 | Eingeleitet | Raymond James | Mkt Perform |
| 2021-06-10 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-03-01 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2021-03-01 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
| 2021-02-26 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2020-10-22 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2020-03-04 | Eingeleitet | Barclays | Equal Weight |
| 2019-11-26 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2019-09-23 | Hochstufung | Guggenheim | Neutral → Buy |
| 2019-05-23 | Fortgesetzt | Goldman | Neutral |
| 2019-02-15 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
| 2018-09-25 | Eingeleitet | Leerink Partners | Mkt Perform |
| 2018-05-23 | Eingeleitet | Citigroup | Buy |
| 2018-04-11 | Bestätigt | Credit Suisse | Outperform |
| 2018-02-15 | Bestätigt | Needham | Buy |
| 2018-02-15 | Bestätigt | SunTrust | Buy |
| 2017-09-15 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2017-08-10 | Bestätigt | Needham | Buy |
| 2017-08-08 | Bestätigt | SunTrust | Buy |
| 2017-08-02 | Hochstufung | Leerink Partners | Mkt Perform → Outperform |
| 2017-06-26 | Herabstufung | Janney | Buy → Neutral |
| 2017-01-17 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2016-10-24 | Eingeleitet | Needham | Buy |
| 2016-06-13 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2016-05-18 | Bestätigt | SunTrust | Buy |
Alle ansehen
Agios Pharmaceuticals Inc Aktie (AGIO) Neueste Nachrichten
Will Agios Pharmaceuticals Inc. see short term momentumSwing Trade & Reliable Intraday Trade Plans - newser.com
How Agios Pharmaceuticals Inc. stock reacts to bond yieldsJuly 2025 Decliners & Expert Verified Stock Movement Alerts - newser.com
What to expect from Agios Pharmaceuticals Inc. in the next 30 days2025 Growth vs Value & Daily Momentum Trading Reports - newser.com
Is Agios Pharmaceuticals Inc. stock supported by strong cash flowsJuly 2025 Momentum & Low Risk Investment Opportunities - newser.com
Will Agios Pharmaceuticals Inc. continue its uptrendJuly 2025 Decliners & Weekly Top Performers Watchlists - newser.com
Has Agios Pharmaceuticals Inc. formed a bullish divergence2025 Year in Review & Daily Stock Trend Reports - newser.com
Why Agios Pharmaceuticals Inc. (8AP) stock gets analyst attentionJuly 2025 Retail & Risk Managed Investment Signals - newser.com
Zacks Research Issues Pessimistic Outlook for AGIO Earnings - MarketBeat
Will Agios Pharmaceuticals Inc. outperform the marketForecast Cut & AI Forecast for Swing Trade Picks - newser.com
Will Agios Pharmaceuticals Inc. (8AP) stock outperform Dow JonesPortfolio Update Report & Weekly Setup with High ROI Potential - newser.com
Analyzing recovery setups for Agios Pharmaceuticals Inc. investorsJuly 2025 Catalysts & Smart Allocation Stock Reports - newser.com
How to use a screener to detect Agios Pharmaceuticals Inc. breakoutsWeekly Earnings Recap & Daily Oversold Bounce Ideas - newser.com
Using R and stats models for Agios Pharmaceuticals Inc. forecasting2025 Trading Volume Trends & Weekly High Return Stock Opportunities - newser.com
Relative strength of Agios Pharmaceuticals Inc. in sector analysisTrade Volume Report & Scalable Portfolio Growth Methods - newser.com
Leading vs lagging indicators on Agios Pharmaceuticals Inc. performanceWeekly Trade Review & Safe Entry Trade Signal Reports - newser.com
Agios Pharmaceuticals' (AGIO) Hold (C-) Rating Reiterated at Weiss Ratings - MarketBeat
Agios Pharmaceuticals (NASDAQ:AGIO) Cut to "Strong Sell" at Zacks Research - MarketBeat
Agios Pharmaceuticals Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Will Agios Pharmaceuticals Inc. stock benefit from commodity prices2025 Historical Comparison & Free Expert Approved Momentum Trade Ideas - newser.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Agios Pharmaceuticals, Inc.AGIO - Eastern Progress
What momentum shifts mean for Agios Pharmaceuticals Inc.July 2025 Sentiment & Accurate Technical Buy Alerts - newser.com
Is Agios Pharmaceuticals Inc. reversing from oversold territoryQuarterly Trade Summary & Free Verified High Yield Trade Plans - newser.com
Published on: 2025-10-02 19:48:50 - newser.com
Agios Pharmaceuticals Hits Day High with 9.64% Surge in Stock Price - Markets Mojo
Published on: 2025-10-01 06:17:51 - newser.com
Agios Pharmaceuticals Inc Stock Analysis and ForecastDividend Yield Trends & Rapid Portfolio Trading Growth - earlytimes.in
Finanzdaten der Agios Pharmaceuticals Inc-Aktie (AGIO)
Umsatz
Nettogewinn
Free Cashflow
ENV
Agios Pharmaceuticals Inc-Aktie (AGIO) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Scadden David | Director |
Oct 08 '25 |
Sale |
41.00 |
200 |
8,200 |
17,603 |
5.15%
1.45%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):